Pasadena, CA, United States of America

Henry Klassen

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Children's Hospital of Orange County, The Schepens Eye Research Institute, Inc.. Active years: 2008-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Henry Klassen. Retrieved from https://idiyas.com/inventor/henry-klassen-5j4a8gcr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile




Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 2008-2012

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Henry Klassen: Innovator in Neural Stem Cell Research

Introduction

Henry Klassen, based in Pasadena, CA, is a trailblazing inventor with a focus on innovations in the field of neural stem cell research. With three patents to his name, he has significantly impacted the understanding and application of neural stem cells in therapeutic contexts. His research has paved the way for advancements in regenerative medicine and offers exciting possibilities for treating various neurological conditions.

Latest Patents

Among Klassen's notable patents is the one on the "Isolation of neural stem cells using gangliosides and other surface markers." This invention identifies a range of molecules present on the surface of multipotent neural stem and progenitor cells (NSCs) using human and murine neural stem cell lines. His findings include NSC-specific markers, gene products, non-protein molecules, and sugar epitopes that are not directly coded in the genome. Collectively, these discoveries provide a means to enrich neural stem cells and progenitor subpopulations, opening avenues for pharmacological manipulation both in vivo and ex vivo.

Another significant patent is centered around the "Isolation and transplantation of retinal stem cells." This invention pertains to the isolation, in vitro propagation, and transplantation of non-pigmented retinal stem cells derived from the neuroretina of the eye. The insights gained from this work hold promise for both ex vivo and in vivo applications, enhancing potential therapeutic strategies for retinal disorders.

Career Highlights

Henry Klassen has made substantial contributions to his field through his work in notable institutions. His affiliation with the Schepens Eye Research Institute, Inc. and the Children's Hospital of Orange County exemplifies his commitment to advancing medical science. His research endeavors have continually focused on the intersection of innovation and practical application, particularly regarding stem cell therapies.

Collaborations

Throughout his career, Klassen has worked collaboratively with esteemed colleagues such as Michael J Young and Michael Schwartz. These partnerships have fostered an environment of innovation and have expanded the reach of his research and inventions, enabling significant advancements in understanding and exploiting neural stem cells.

Conclusion

Henry Klassen's innovative work in isolating and utilizing neural stem cells represents a leap forward in regenerative medicine. His contributions have profound implications for treating various diseases, particularly those affecting the nervous system. With a strong foundation of patents and collaborative efforts, he continues to be a key figure in the landscape of biomedical research, ultimately aiming to transform therapeutic strategies and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…